French biotech snags vaccine grant; Novavax rises on early RSV data;

> French biotech Imaxio and its partners have won a grant to develop a Staphylococcus aureus vaccine. Release (pdf)

> Positive results from an early-phase respiratory virus vaccine trial pushed Novavax ($NVAX) shares higher. News

> Indian firm Biological E has won a $200 million deal to supply pentavalent vaccines to Egypt. Article

> A genital herpes vaccine is advancing toward clinical trials. Piece

> Indian regulators continue to investigate the relabeling of vaccines by Panacea Biotec. Item

> A malaria vaccine is tipped to enter clinical trials after impressing in mice. Study

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

Find out how PDA can help you succeed with custom solutions and training for your employees – at your facility, our facility, or virtually.

Iowa State University is working on a room-temp-stable nasal spray vaccine for COVID-19, and it recently tapped device maker Zeteo for support.

Pfizer's shot will go before an FDA expert panel on Dec. 10, with Moderna's review pegged for the 17th, Warp Speed chief Moncef Slaoui, Ph.D., said.